-
Product Insights
Chowchilla Biomass Power Plant
Chowchilla Biomass Power Plant is a biopower project located in California, United States. The project is owned by Global Ampersand, LLC. The project came online in 1989. Empower your strategies with our Chowchilla Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
Merced Biomass Power Plant
Merced Biomass Power Plant is a biopower project located in California, United States. The project is owned by Global Ampersand, LLC. The project came online in 1988. Empower your strategies with our Merced Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Thematic Analysis
Digital Therapeutics – Thematic Intelligence
Explore actionable trends and insights with the following data sets in the ‘Digital Therapeutics’ report: Market analysis of approved and reimbursed digital therapeutic products by region. Case studies with in-depth insight into some of the most recent and most influential developments in the digital therapeutics theme. Product profiles of disruptive digital therapeutic products across key therapeutic areas. A focused chapter on the key healthcare, technology, macroeconomic, and regulatory trends impacting digital therapeutics, and a review of how these trends will...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Product Insights
Digital Health Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) and Segment Forecast, 2022-2027
The digital health in immunology market size was valued at US$6.07 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 24.2% during 2022-2027. Digital health has a broad scope and includes the use of wearable devices, mobile health, telehealth, health information technology, and telemedicine. Digital health applications in immunology have gained significant momentum owing to the following factors: Enhanced access to healthcare Affordable cost of healthcare Improve the quality of care Reduce any...
-
Report Bundle
58% offTech in Pharma – Report Bundle (7 Reports)
Tech in Pharma Bundle Report Overview Although the pharmaceutical industry had been slow to adopt technological innovations, the onset of COVID-19 has dramatically altered the situation. The latest technologies, Augmented Reality (AR), Big Data, and Artificial Intelligence (AI), among others, will assist pharmaceutical companies in speeding up the research and development process, creating personalized products, and conducting testing in novel ways. Finally, these technologies will improve healthcare effectiveness and efficiency thereby transforming the patient and provider experience. Explore actionable market...
-
Thematic Analysis
Digital Health in Immunology – Thematic Research
Digital technologies are constantly evolving and finding new applications in healthcare. These tools can be used to track health, deliver therapeutic interventions, and contribute to research. They include digital therapeutics (DTx), mobile health, (mHealth), wearable technology, digital biomarkers, telemedicine, virtual reality (VR), and augmented reality (AR). Using search terms relevant to rheumatology, dermatology, and gastroenterology, approximately 2,000 mobile apps were identified from third-party data provider Airnow Data. More than 300 of the apps are for dermatology, followed by gastroenterology and...